With cases as at Sept 16 reaching over 800 and expected to reach over 1,000 by the next week, Singapore is ramping up its testing frequency. This bodes well for the group’s Covid-19 testing arm Acumen.
The increase in Covid-19 cases in Singapore lately may be causing a stir in the community, but for dental group Q&M Dental, this is an opportunity.
As such, CGS-CIMB and Maybank Kim Eng have kept their “buy” calls on the stock with target price of 89 cents and 85 cents, respectively. Furthermore, the stock has pulled back by about 20% from its recent peak following its 2QFY2021 results on profit taking and general market weakness. Hence, this creates a buying opportunity for investors who missed the previous rally.
![[19/05/26] new top stories](/_next/image?url=https%3A%2F%2Fedgemarkets-transferred.s3-ap-southeast-1.amazonaws.com%2FPEO_KUNHEE_PARK_01_AC_2.jpg%3FTd3bG7fJqxPW3hMZRxhyfGgI25yRRD5v&w=640&q=75)
